$CPIX staging again. profits . $5.28

net revenues
were $9.7 million, up nearly 50% from the prior year period.
Operating cash flow was $4.0 million for the nine months ended
September 30, 2014, as the Company managed expenses in line
with revenue. Cumberland returned to profitability in 2014 with $1.8
million in net income during the first nine months of the year or $0.10
per diluted share.



Website

80 % Buy



Shares Outstanding: 17.36M
Float: 10.77M
% Held by Insiders1 36.94%
% Held by Institutions: 38.50%
Shares Short (as of Nov 28, 2014): 233.02K
Short Ratio (as of Nov 28, 2014): 4.90
Short % of Float (as of Nov 28, 2014): 2.70%
Shares Short (prior month): 232.93K



10-Q 11/7/14
Summary

Recent Trades


Headlines

Saturday, November 15, 2014

CUMBERLAND PHARMACEUTICALS INC FinancialsEDGAR Online Financials (Sat, Nov 15)

Sunday, November 9, 2014

10-Q for Cumberland Pharmaceuticals, Inc.Company Spotlight (Sun, Nov 9)

Friday, November 7, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Fri, Nov 7)

Tuesday, November 4, 2014

Cumberland Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET todayCCBN (Tue, Nov 4)
Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial ResultsPR Newswire (Tue, Nov 4)
Q3 2014 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseCCBN (Tue, Nov 4)

Tuesday, October 21, 2014

Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014PR Newswire (Tue, Oct 21)

Tuesday, October 14, 2014

Caldolor® Safely Treats Fever In Hospitalized ChildrenPR Newswire (Tue, Oct 14)

Friday, October 10, 2014

Caldolor® Provides Favorable Inflammatory Response Results In Laparoscopic Cholecystectomy Surgery PatientsPR Newswire (Fri, Oct 10)

Friday, August 8, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Fri, Aug

Tuesday, August 5, 2014

Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial ResultsPR Newswire (Tue, Aug 5)

Tuesday, July 22, 2014

Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014PR Newswire (Tue, Jul 22)

Wednesday, July 2, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MaterEDGAR Online (Wed, Jul 2)

Monday, May 19, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Mon, May 19)

Tuesday, May 13, 2014

Cumberland Pharmaceuticals' (CPIX) CEO A. J. Kazimi on Q1 2014 Results - Earnings Call Transcriptat Seeking Alpha (Tue, May 13)
Cumberland Pharmaceuticals Reports First Quarter 2014 Financial ResultsPR Newswire (Tue, May 13)

Monday, May 12, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, May 12)

Friday, May 9, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other EventsEDGAR Online (Fri, May 9)

Wednesday, May 7, 2014

Cumberland Pharmaceuticals Launches Vaprisol® PromotionPR Newswire (Wed, May 7)

Tuesday, May 6, 2014

Cumberland Pharmaceuticals And Gloria Pharmaceuticals Announce Joint Research & Development InvestmentPR Newswire (Tue, May 6)